CD8A and neoplasm: In summary, our results suggest that NLGP prophylaxis educate whole immune system in such a way that after tumor challenge antigen presenting cells efficiently prime effector CD8+ T cells, which in due course kill tumor cells to reduce tumor promoting growth factor burden within TME.